Large quantitative models: How AI is accelerating drug discovery
Large quantitative models are revolutionizing drug discovery by cutting years off R&D while unlocking therapies for diseases once deemed untreatable.
SandboxAQ leverages the compound effects of artificial intelligence (AI) and quantum technologies (AQ) to solve hard challenges impacting society. Its AQ technologies include crypto-agile security, quantum sensing and quantum simulation and optimization for global organizations. With its solutions, it can bring clients into the quantum era and provide a competitive advantage, even before scalable and fault-tolerant quantum computers become widely available. SandboxAQ is backed by Eric Schmidt, T. Rowe Price, Marc Benioff, Jim Breyer, Guggenheim Partners, Amadeus Capital and other investors.
Large quantitative models are revolutionizing drug discovery by cutting years off R&D while unlocking therapies for diseases once deemed untreatable.
AI and quantum simulation promise to redefine how to design therapeutics while providing the often lacking datasets needed for better drug development.
The Centre for Cybersecurity is reinforcing the importance of cybersecurity as a strategic priority and drives global public-private action to address systemic cybersecurity challenges.
The Centre for Energy and Materials is driving initiatives and coalitions to ensure the energy transition is sustainable, secure, resilient and affordable.




